Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 3Recruiting 2Completed 2Terminated 1Active not recruiting 1

Sponsor Class

UNKNOWN 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Uterine Cervical Neoplasms 3Esophageal Neoplasms 3Lymphatic Metastasis 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Recurrence 1Pathologic Complete Response 1Neoplasm Metastasis 1Melanoma 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Cisplatin 31Paclitaxel 26Radiotherapy 21Fluorouracil 19camrelizumab 11Radiation 11Oxaliplatin 10Docetaxel 10Carboplatin 9Capecitabine 9Esophagectomy 8Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 6Endoscopic Mucosal Resection 6Drug Therapy 6apatinib 5Leucovorin 5Chemoradiotherapy 5nedaplatin 4S 1 (combination) 4Preoperative Exercise 4Neoadjuvant Therapy 4Irinotecan 4Endoscopy 4Cetuximab 4Albumin-Bound Paclitaxel 4pembrolizumab 3TP protocol 3Radiotherapy, Adjuvant 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Esophageal Neoplasms × TP protocol × Clear all
NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

NCT02461043 2015-09-01

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma

ChineseAMS

Phase 3 Unknown
386 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01444547 2014-05-06

A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin

ChineseAMS

Phase 2 Unknown
92 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡